Effect of Kinesiotape on Postural Control in Non-operated Anterior Cruciate Ligament Subjects

NCT ID: NCT05256420

Last Updated: 2022-02-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

38 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-10

Study Completion Date

2022-08-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Anterior cruciate ligament (ACL) injuries are the most common traumatic knee ligament injuries. This lesion has a devastating influence on patients' activity levels and quality of life. ACL injuries are most frequent between the ages of 15 and 45 years. Individuals who choose conservative treatment must undergo physical therapy to strengthen muscles around the knee, notably the quadriceps femoris and hamstring muscles. It had been described that in absence of surgical treatment, the knee remains unstable and vulnerable to injury having a much poorer prognosis. This study aims to analyze the effectiveness of neuromuscular taping (kinesiotape) compared to placebo in patients with non-operated anterior cruciate ligament rupture.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knee Injuries Cruciate Ligament Rupture Anterior Cruciate Ligament Injuries Motor Control Balance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Kinesiotape

Application of a kinesiotape bandage on the knee.

Group Type EXPERIMENTAL

Kinesiotape

Intervention Type DEVICE

Application of a kinesiotape bandage on the knee.

Sham Bandage

Application of a sham bandage on the knee.

Group Type SHAM_COMPARATOR

Sham Bandage

Intervention Type DEVICE

Application of a sham bandage on the knee.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Kinesiotape

Application of a kinesiotape bandage on the knee.

Intervention Type DEVICE

Sham Bandage

Application of a sham bandage on the knee.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients of both sexes, diagnosed with ACL rupture (clinical and imaging) between 18 and 60 years old and not yet operated.
* Rupture isolated or combined with meniscopathy including bucket-handle.
* Partial or complete ACL rupture.

Exclusion Criteria

* Cognitive impairment that prevents understanding of simple commands.
* Unhealed wounds in the knee complex.
* Severe skin diseases and alterations.
* Previous history of allergy to any type of bandage.
* Neurological disease with impaired balance.
* Manifest deformity of the musculoskeletal system
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidad Rey Juan Carlos

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Josue Fernandez Carnero

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universidad Rey Juan Carlos

Alcorcón, Madrid, Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Víctor Navarro López, PhD student

Role: CONTACT

697371075

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Víctor Navarro López, PhD student

Role: primary

697371075

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KTBALANCE080222

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.